Dr. Reddy's Files FDA Drugmaster Application For Nexium

Law360, New York (July 16, 2004, 12:00 AM EDT) -- Indian drug maker Dr. Reddy’s has made a preliminary filing with the U.S. Food and Drug Administration, paving the way for an application for a generic version of AstraZeneca's blockbuster heartburn medicine Nexium.

Dr Reddy's has filed a "drugmaster" document with the FDA, usually the precursor to a full-blown patent challenge. The submission of a drugmaster file with the FDA typically precedes an abbreviated new drug application (ANDA).

Dr. Reddy’s formal application could be prepared within six months to file for regulatory approval for its version...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.